{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:51:30Z","timestamp":1760151090045,"version":"build-2065373602"},"reference-count":25,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Young Teachers Innovation Project of China Agricultural University","award":["2018QC142"],"award-info":[{"award-number":["2018QC142"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31802162"],"award-info":[{"award-number":["31802162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["6202017"],"award-info":[{"award-number":["6202017"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nanomaterials"],"abstract":"<jats:p>The hepatitis E virus (HEV) is an important pathogen that threatens global public health. One-third of the world\u2019s population lives in the epidemic area of HEV, causing 20 million infections and 70,000 deaths annually. In China, HEV transmission has changed from human-to-human transmission of HEV1 to zoonotic transmission of HEV4, causing hepatitis outbreaks throughout the country. Protecting vulnerable groups, such as practitioners related to animal husbandry and downstream consumers who are immune deficient or pregnant, from HEV infections is an urgent task. At present, the commercial human vaccine, Hecolin\u00ae (HEV 239 vaccine), is licensed for use only in China. HEV 239 vaccine is a human vaccine developed for HEV1. Although it has a cross-protective effect on HEV4, the level of immune protection is still different. To address the transformation of domestic HEV transmission modes, there is an urgent need to develop a new vaccine against zoonotic HEV4. P206@PLGA is a vaccine candidate in which nanomaterials are used to encapsulate viral capsid proteins for the immunization of livestock animals. Our experiments show that P206@PLGA has excellent biocompatibility and safety. In addition, P206@PLGA can effectively induce animals to produce a high titer of antibodies against HEV4, and thus has the potential to become a veterinary vaccine for the prevention of HEV. This approach provides a new concept for HE prevention to reduce the transmission of HEV in farms and protect susceptible populations.<\/jats:p>","DOI":"10.3390\/nano12040595","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T02:35:51Z","timestamp":1644546951000},"page":"595","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preparation and Immune Effect of HEV ORF2 P206@PLGA Nanoparticles"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-8557","authenticated-orcid":false,"given":"Yifei","family":"Yang","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, China Agricultural University, No. 2 West Road Yuanmingyuan, Beijing 100193, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenning","family":"Sun","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, China Agricultural University, No. 2 West Road Yuanmingyuan, Beijing 100193, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huopeng","family":"Li","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, China Agricultural University, No. 2 West Road Yuanmingyuan, Beijing 100193, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jijing","family":"Tian","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, China Agricultural University, No. 2 West Road Yuanmingyuan, Beijing 100193, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyong","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, China Agricultural University, No. 2 West Road Yuanmingyuan, Beijing 100193, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianlong","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, China Agricultural University, No. 2 West Road Yuanmingyuan, Beijing 100193, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.vetmic.2009.03.017","article-title":"Hepatitis E virus: Animal reservoirs and zoonotic risk","volume":"140","author":"Meng","year":"2010","journal-title":"Vet Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1016\/0168-8278(91)90049-H","article-title":"Hepatitis E virus genome: Molecular features, expression of immunoreactive proteins and sequence divergence","volume":"13","author":"Bradley","year":"1991","journal-title":"J. Hepatol."},{"key":"ref_3","first-page":"1675","article-title":"The complete sequence of hepatitis E virus genotype 4 reveals an alternative strategy for translation of open reading frames 2 and 3","volume":"81","author":"Wang","year":"2000","journal-title":"J. Gen. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/JVI.02259-06","article-title":"Initiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivo","volume":"81","author":"Huang","year":"2007","journal-title":"J. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5604\/16652681.1226815","article-title":"High Clinical Manifestation Rate in an Imported Outbreak of Hepatitis E Genotype 1 Infection in a German Group of Travellers Returning from India","volume":"16","author":"Pischke","year":"2017","journal-title":"Ann. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3201\/eid1909.130013","article-title":"Hepatitis E Virus Genotype 4, Nanjing, China, 2001\u20132011","volume":"19","author":"Dai","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"ref_7","first-page":"581","article-title":"Investigation of Hepatitis E Outbreak Among Refugees\u2014Upper Nile, South Sudan, 2012\u20132013","volume":"62","author":"Thomson","year":"2013","journal-title":"MMWR-Morb. Mortal. Wkly. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(07)61441-X","article-title":"Hepatitis E associated with surgical training on pigs","volume":"370","author":"Colson","year":"2007","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jcv.2013.08.030","article-title":"Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals","volume":"58","author":"Chaussade","year":"2013","journal-title":"J. Clin. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.4269\/ajtmh.2007.77.893","article-title":"Autochthonous hepatitis E infection in a slaughterhouse worker","volume":"77","author":"Mateos","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.vaccine.2008.12.061","article-title":"Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine","volume":"27","author":"Zhang","year":"2009","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: A large-scale, randomised, double-blind placebo-controlled, phase 3 trial","volume":"376","author":"Zhu","year":"2010","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.4155\/tde-2016-0051","article-title":"Novel biodegradable nanocarriers for enhanced drug delivery","volume":"7","author":"Gagliardi","year":"2016","journal-title":"Ther. Deliv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","article-title":"PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect","volume":"63","author":"Acharyaand","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_15","first-page":"1","article-title":"Biodegradable PLGA-b-PEG polymeric nanoparticles: Synthesis, properties, and nanomedical applications as drug delivery system","volume":"14","author":"Locatelliand","year":"2012","journal-title":"J. Nanoparticle Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: An overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control Release"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.1021\/ie500760m","article-title":"Validation of a Mathematical Model for the Description of Hydrophilic and Hydrophobic Drug Delivery from Biodegradable Foams: Experimental and Comparison Using Indomethacin as Released Drug","volume":"53","author":"Cabezas","year":"2014","journal-title":"Ind. Eng. Chem. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1128\/JVI.00444-13","article-title":"The hepatitis E virus capsid C-terminal region is essential for the viral life cycle: Implication for viral genome encapsidation and particle stabilization","volume":"87","author":"Shiota","year":"2013","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcis.2014.12.083","article-title":"Cellular uptake, antioxidant and antiproliferative activity of entrapped alpha-tocopherol and gamma-tocotrienol in poly (lactic-co-glycolic) acid (PLGA) and chitosan covered PLGA nanoparticles (PLGA-Chi)","volume":"445","author":"Alqahtani","year":"2015","journal-title":"J. Colloid Interface Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1002\/jbm.a.35498","article-title":"Cytotoxicity and intracellular fate of PLGA and chitosan-coated PLGA nanoparticles in Madin-Darby bovine kidney (MDBK) and human colorectal adenocarcinoma (Colo 205) cells","volume":"103","author":"Trif","year":"2015","journal-title":"J. Biomed. Mater. Res. A"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.drudis.2011.04.006","article-title":"Particulate vaccines: On the quest for optimal delivery and immune response","volume":"16","author":"Rejman","year":"2011","journal-title":"Drug Discov. Today"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Chen, X., Kim, P., Farinelli, B., Doukas, A., Yun, S.H., Gelfand, J.A., Anderson, R.R., and Wu, M.X. (2010). A novel laser vaccine adjuvant increases the motility of antigen presenting cells. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013776"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.biomaterials.2014.04.022","article-title":"Immune responses to vaccines involving a combined antigen-nanoparticle mixture and nanoparticle-encapsulated antigen formulation","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.180.8.5402","article-title":"The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells","volume":"180","author":"Seubert","year":"2008","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2011.01.045","article-title":"Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen","volume":"408","author":"Saini","year":"2011","journal-title":"Int. J. Pharm."}],"container-title":["Nanomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-4991\/12\/4\/595\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:17:58Z","timestamp":1760134678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-4991\/12\/4\/595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["nano12040595"],"URL":"https:\/\/doi.org\/10.3390\/nano12040595","relation":{},"ISSN":["2079-4991"],"issn-type":[{"type":"electronic","value":"2079-4991"}],"subject":[],"published":{"date-parts":[[2022,2,10]]}}}